PHENYTOIN SHORTENS THE HALF-LIFE OF THE HYPOXIC CELL RADIOSENSITIZER MISONIDAZOLE IN MAN - IMPLICATIONS FOR POSSIBLE REDUCED TOXICITY

被引：32
|
作者：
WORKMAN, P [1 ]
BLEEHEN, NM [1 ]
WILTSHIRE, CR [1 ]
机构：
[1] UNIV CAMBRIDGE,DEPT CLIN ONCOL & RADIOTHERAPEUT,CAMBRIDGE,ENGLAND
来源：
BRITISH JOURNAL OF CANCER | 1980年 / 41卷 / 02期
关键词：
D O I：
10.1038/bjc.1980.43
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：302 / 304
页数：3
相关论文
共 10 条
  • [1] TOXICITY OF RADIOSENSITIZER MISONIDAZOLE TOWARDS HYPOXIC CELLS INVITRO - MODEL FOR MOUSE AND MAN
    STRATFORD, IJ
    ADAMS, GE
    BRITISH JOURNAL OF RADIOLOGY, 1978, 51 (609): : 745 - 746
  • [2] A TOXICITY AND PHARMACOKINETIC STUDY IN MAN OF THE HYPOXIC-CELL RADIOSENSITIZER RSU-1069
    HORWICH, A
    HOLLIDAY, SB
    DEACON, JM
    PECKHAM, MJ
    BRITISH JOURNAL OF RADIOLOGY, 1986, 59 (708): : 1238 - 1240
  • [3] Nanocomplexes of Biodegradable Anticancer Macromolecules: Prolonged Plasma Half-Life, Reduced Toxicity, and Increased Tumor Targeting
    Leong, Jiayu
    Tay, Joyce
    Yang, Shengcai
    Yang, Chuan
    Tan, Eddy Wei Ping
    Wang, Yanming
    Tan, Bing Qian
    Hor, Sherwin
    Chua, Yau Hong
    Tan, Jeremy Pang Kern
    Chen, Qingfeng
    Hedrick, James L.
    Yang, Yi Yan
    ADVANCED HEALTHCARE MATERIALS, 2023, 12 (19)
  • [4] STUDIES ON ENZYME ELIMINATION .1. HALF-LIFE PERIOD OF SOME CELL ENZYMES IN MAN
    BAR, U
    OHLENDORF, S
    KLINISCHE WOCHENSCHRIFT, 1970, 48 (13): : 776 - +
  • [5] Modulating huntingtin half-life alters polyglutamine-dependent aggregate formation and cell toxicity
    Kaytor, MD
    Wilkinson, KD
    Warren, ST
    JOURNAL OF NEUROCHEMISTRY, 2004, 89 (04) : 962 - 973
  • [6] Modulating huntingtin half-life alters polyglutamine-dependent aggregate formation and cell toxicity.
    Kaytor, MD
    Iber, JC
    Warren, ST
    AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 67 (04) : 365 - 365
  • [7] THE HALF-LIFE OF IMMUNOGLOBULIN MESSENGER-RNA INCREASES DURING B-CELL DIFFERENTIATION - A POSSIBLE ROLE FOR TARGETING TO MEMBRANE-BOUND POLYSOMES
    MASON, JO
    WILLIAMS, GT
    NEUBERGER, MS
    GENES & DEVELOPMENT, 1988, 2 (08) : 1003 - 1011
  • [8] Characterization of an Anti-CD70 Half-Life Extended Bispecific T-Cell Engager (HLE-BiTE) and Associated On-Target Toxicity in Cynomolgus Monkeys
    Harper, Tod, Jr.
    Sharma, Amy
    Kaliyaperumal, Sarav
    Fajardo, Flordeliza
    Hsu, Katie
    Liu, Lily
    Davies, Rhian
    Wei, Yu-Ling
    Zhan, Jinghui
    Estrada, Juan
    Kvesic, Majk
    Nahrwold, Lisa
    Deisting, Wibke
    Panzer, Marc
    Cooke, Keegan
    Lebrec, Herve
    Nolan-Stevaux, Olivier
    TOXICOLOGICAL SCIENCES, 2022, 189 (01) : 32 - 50
  • [9] NM28-2746, a reduced affinity bivalent mesothelin-binding MATCH4 T cell engager, with half-life extension, increases selectivity for killing of mesothelin-overexpressing cells
    Chatterjee, Bithi
    Hess, Christian
    Snell, Daniel
    Gunde, Tea
    Warmuth, Stefan
    Simonin, Alexandre
    Brock, Matthias
    Spiga, Fabio
    Johansson, Maria
    Weinert, Christopher
    Tietz, Julia
    Kirk, Niels
    Bassler, Nicole
    Mahler, Dana
    Diem, Dania
    Carrella, Alessandra
    Giezendanner, Noreen
    Alberti, Alessandra
    Gambino, Giorgio
    Wickihalder, Belinda
    Bommer, Bettina
    Muntwiler, Simone
    Yaman, Yasemin
    Flueckiger, Naomi
    Heiz, Robin
    Wagen, Sandro
    Urech, David
    CANCER RESEARCH, 2022, 82 (12)
  • [10] TWICE-DAILY INTRAVENOUS (IV) BUSULFAN (Bu) X 4 DAYS IN CHILDREN UNDERGOING A REDUCED-INTENSITY CONDITIONING (RIC) REGIMEN WITH ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (AlloHSCT) IS SAFE AND WELL-TOLERATED BUT RESULTS IN SIGNIFICANTLY INCREASED Bu CLEARANCE (CL) AND DECREASED AREA UNDER THE CURVE (AUC) AND HALF-LIFE (t1/2) WHEN COMPARED TO IV BU TWICE-DAILY DOSING PHARMACOKINETICS (PK) IN ADULTS
    Waxman, I
    Bhatia, M.
    Milone, M.
    Shaw, L. M.
    Baldinger, L.
    Militano, O.
    Garvin, J.
    George, D.
    Bradley, M. B.
    Satwani, P.
    Schwartz, J.
    Wolownik, K.
    Foley, S.
    Hawks, R.
    Jin, Z. Z.
    Baxter-Lowe, L. A.
    van de Ven, C.
    Cairo, M. S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (02) : 85 - 85
1